NAKA Quote, Financials, Valuation and Earnings

Encompass Health Corp. has a net margin of -22162.75% compared to Kindly MD, Inc.'s net margin of 11.82%. Kindly MD, Inc.'s return on equity of -91.57% beat Encompass Health Corp.'s return on equity of 24.34%.

Kindly MD, Inc. has a consensus price target of $1.25, signalling upside risk potential of 211.41%. On the other hand Encompass Health Corp. has an analysts' consensus of $140.33 which suggests that it could grow by 41.22%. Given that Kindly MD, Inc. has higher upside potential than Encompass Health Corp., analysts believe Kindly MD, Inc. is more attractive than Encompass Health Corp..

Kindly MD, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Encompass Health Corp. has a beta of 0.756, suggesting its less volatile than the S&P 500 by 24.396%.

Kindly MD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health Corp. offers a yield of 0.73% to investors and pays a quarterly dividend of $0.19 per share. Kindly MD, Inc. pays -- of its earnings as a dividend. Encompass Health Corp. pays out 14.35% of its earnings as a dividend. Encompass Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Kindly MD, Inc. quarterly revenues are $388.2K, which are smaller than Encompass Health Corp. quarterly revenues of $1.5B. Kindly MD, Inc.'s net income of -$86M is lower than Encompass Health Corp.'s net income of $174.7M. Notably, Kindly MD, Inc.'s price-to-earnings ratio is -- while Encompass Health Corp.'s PE ratio is 18.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD, Inc. is 11.25x versus 1.75x for Encompass Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Pediatrix Medical Group, Inc. has a net margin of -22162.75% compared to Kindly MD, Inc.'s net margin of 14.55%. Kindly MD, Inc.'s return on equity of -91.57% beat Pediatrix Medical Group, Inc.'s return on equity of 20.22%.

Kindly MD, Inc. has a consensus price target of $1.25, signalling upside risk potential of 211.41%. On the other hand Pediatrix Medical Group, Inc. has an analysts' consensus of $22.67 which suggests that it could grow by 2.06%. Given that Kindly MD, Inc. has higher upside potential than Pediatrix Medical Group, Inc., analysts believe Kindly MD, Inc. is more attractive than Pediatrix Medical Group, Inc..

Kindly MD, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pediatrix Medical Group, Inc. has a beta of 0.735, suggesting its less volatile than the S&P 500 by 26.542%.

Kindly MD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pediatrix Medical Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kindly MD, Inc. pays -- of its earnings as a dividend. Pediatrix Medical Group, Inc. pays out -- of its earnings as a dividend.

Kindly MD, Inc. quarterly revenues are $388.2K, which are smaller than Pediatrix Medical Group, Inc. quarterly revenues of $492.9M. Kindly MD, Inc.'s net income of -$86M is lower than Pediatrix Medical Group, Inc.'s net income of $71.7M. Notably, Kindly MD, Inc.'s price-to-earnings ratio is -- while Pediatrix Medical Group, Inc.'s PE ratio is 11.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD, Inc. is 11.25x versus 0.99x for Pediatrix Medical Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute, Inc. has a net margin of -22162.75% compared to Kindly MD, Inc.'s net margin of -10.08%. Kindly MD, Inc.'s return on equity of -91.57% beat The Oncology Institute, Inc.'s return on equity of -9486.64%.

Kindly MD, Inc. has a consensus price target of $1.25, signalling upside risk potential of 211.41%. On the other hand The Oncology Institute, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 81.06%. Given that Kindly MD, Inc. has higher upside potential than The Oncology Institute, Inc., analysts believe Kindly MD, Inc. is more attractive than The Oncology Institute, Inc..

Kindly MD, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Oncology Institute, Inc. has a beta of 0.151, suggesting its less volatile than the S&P 500 by 84.902%.

Kindly MD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kindly MD, Inc. pays -- of its earnings as a dividend. The Oncology Institute, Inc. pays out -- of its earnings as a dividend.

Kindly MD, Inc. quarterly revenues are $388.2K, which are smaller than The Oncology Institute, Inc. quarterly revenues of $136.6M. Kindly MD, Inc.'s net income of -$86M is lower than The Oncology Institute, Inc.'s net income of -$13.8M. Notably, Kindly MD, Inc.'s price-to-earnings ratio is -- while The Oncology Institute, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD, Inc. is 11.25x versus 0.67x for The Oncology Institute, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

U.S. Physical Therapy, Inc. has a net margin of -22162.75% compared to Kindly MD, Inc.'s net margin of 9.98%. Kindly MD, Inc.'s return on equity of -91.57% beat U.S. Physical Therapy, Inc.'s return on equity of 8.6%.

Kindly MD, Inc. has a consensus price target of $1.25, signalling upside risk potential of 211.41%. On the other hand U.S. Physical Therapy, Inc. has an analysts' consensus of $105.33 which suggests that it could grow by 20.42%. Given that Kindly MD, Inc. has higher upside potential than U.S. Physical Therapy, Inc., analysts believe Kindly MD, Inc. is more attractive than U.S. Physical Therapy, Inc..

Kindly MD, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison U.S. Physical Therapy, Inc. has a beta of 1.290, suggesting its more volatile than the S&P 500 by 28.981%.

Kindly MD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. U.S. Physical Therapy, Inc. offers a yield of 2.06% to investors and pays a quarterly dividend of $0.45 per share. Kindly MD, Inc. pays -- of its earnings as a dividend. U.S. Physical Therapy, Inc. pays out 95.62% of its earnings as a dividend. U.S. Physical Therapy, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Kindly MD, Inc. quarterly revenues are $388.2K, which are smaller than U.S. Physical Therapy, Inc. quarterly revenues of $197.1M. Kindly MD, Inc.'s net income of -$86M is lower than U.S. Physical Therapy, Inc.'s net income of $19.7M. Notably, Kindly MD, Inc.'s price-to-earnings ratio is -- while U.S. Physical Therapy, Inc.'s PE ratio is 36.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD, Inc. is 11.25x versus 1.75x for U.S. Physical Therapy, Inc.. Usually stocks with elevated PS ratios are considered overvalued.